TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients

Relapse rates in surgically resected non-small-cell lung cancer (NSCLC) patients are between 30% and 45% within five years of diagnosis, which shows the clinical need to identify those patients at high risk of recurrence. The eighth TNM staging system recently refined the classification of NSCLC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalba, Maria, Exposito, Francisco, Pajares, Maria Jose, Sainz, Cristina, Redrado, Miriam, Remirez, Ana, Wistuba, Ignacio, Behrens, Carmen, Jantus-Lewintre, Eloisa, Camps, Carlos, Montuenga, Luis M., Pio, Ruben, Lozano, Maria Dolores, de Andrea, Carlos, Calvo, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947244/
https://www.ncbi.nlm.nih.gov/pubmed/31817025
http://dx.doi.org/10.3390/jcm8122134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947244/
https://www.ncbi.nlm.nih.gov/pubmed/31817025
http://dx.doi.org/10.3390/jcm8122134

Ejemplares similares